Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
Clinical trial NCT03719586 · COMPLETED
Trial details
- NCT number
- NCT03719586
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-21
- Primary completion
- 2019-09-09
- Enrollment
- 681
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.